- Tuteja R. Malaria—an overview. FEBS J. 2007;274(18):4670–4679. doi:10.1111/j.1742-4658.2007.05997.x.
- Cowman AF, Healer J, Marapana D, et al. Malaria: biology and disease. Cell. 2016;167(3):610–624. doi:10.1016/j.cell.2016.07.055.
- Miller LH, Ackerman HC, Su XZ, et al. Malaria biology and disease pathogenesis: insights for new treatments. Nat Med. 2013;19(2):156–167. doi:10.1038/nm.3073.
- World Health Organisation. Malaria. https://www.who.int/news-room/fact-sheets/detail/malaria. Published March 29, 2023.
- Fletcher TE, Beeching NJ. Malaria. J R Army Med Corps. 2013;159(3):158–166. doi:10.1136/jramc-2013-000112.
- Sitali L, Miller JM, Mwenda MC, et al. Distribution of Plasmodium species and assessment of performance of diagnostic tools used during a malaria survey in Southern and Western Provinces of Zambia. Malar J. 2019;18:130.
- Phillips MA, Burrows JN, Manyando C, et al. Malaria. Nat Rev Dis Primers. 2017;3:17050. doi:10.1038/nrdp.2017.50.
- Garcia LS. Malaria. Clin Lab Med. 2010;30(1):93–129. doi:10.1016/j.cll.2009.10.001.
- Dye-Braumuller KC, Kanyangarara M. Malaria in the USA: how vulnerable are we to future outbreaks? Curr Trop Med Rep. 2021;8(1):43–51. doi:10.1007/s40475-020-00224-z.
- MacArthur J, Levin A, Roberts J, et al. Malaria surveillance: United States, 1997. In CDC surveillance summaries (March 30). MMWR. 2001;50(No. SS-1):25–29.
- Jerrard DA, Broder JS, Hanna JR, et al. Malaria: a rising incidence in the United States. J Emerg Med. 2002;23(1):23–33. doi:10.1016/s0736-4679(02)00457-2/.
- Mace KE, Arguin PM, Lucchi NW, et al. Malaria surveillance—United States, 2016. MMWR Surveill Summ. 2019;68(5):1–35. doi:10.15585/mmwr.ss6805a1.
- Daily JP, Minuti A, Khan N. Diagnosis, treatment, and prevention of malaria in the US: a review. JAMA. 2022;328(5):460–471. doi:10.1001/jama.2022.12366.
- Greenwood BM, Fidock DA, Kyle DE, et al. Malaria: progress, perils, and prospects for eradication. J Clin Invest. 2008;118(4):1266–1276. doi:10.1172/JCI33996.
- Centers for Disease Control and Prevention. Malaria in Florida; 2023, July 24. https://www.cdc.gov/malaria/new_info/2023/malaria_florida.html.
- Meibalan E, Marti M. Biology of malaria transmission. Cold Spring Harb Perspect Med. 2017;7(3):a025452. doi:10.1101/cshperspect.a025452.
- Akide Ndunge OB, Kilian N, Salman MM. Cerebral malaria and neuronal implications of Plasmodium falciparum infection: from mechanisms to advanced models. Adv Sci. 2022;9(36):e2202944. doi:10.1002/advs.202202944.
- Milner DA Jr. Malaria pathogenesis. Cold Spring Harb Perspect Med. 2018;8(1):a025569. doi:10.1101/cshperspect.a025569.
- Hemmer CJ, Lehr HA, Westphal K, et al. Plasmodium falciparum malaria: reduction of endothelial cell apoptosis in vitro. Infect Immun. 2005;73(3):1764–1770. doi:10.1128/IAI.73.3.1764-1770.2005.
- Holm AE, Gomes LC, Marinho CRF, et al. Prevalence of cardiovascular complications in malaria: a systematic review and meta-analysis. Am J Trop Med Hyg. 2021;104(5):1643–1650. doi:10.4269/ajtmh.20-1414.
- Trivedi S, Chakravarty A. Neurological complications of malaria. Curr Neurol Neurosci Rep. 2022;22(8):499–513. doi:10.1007/s11910-022-01214-6.
- Kariuki SN, Williams TN. Human genetics and malaria resistance. Hum Genet. 2020;139(6–7):801–811. doi:10.1007/s00439-020-02142-6.
- Balaji SN, Deshmukh R, Trivedi V. Severe malaria: biology, clinical manifestation, pathogenesis and consequences. J Vector Borne Dis. 2020;57(1):1–13. doi:10.4103/0972-9062.308793.
- Wooldridge G, Nandi D, Chimalizeni Y, et al. Cardiovascular findings in severe malaria: a review. Glob Heart. 2020;15(1):75. doi:10.5334/gh.789.
- Val F, Avalos S, Gomes AA, et al. Are respiratory complications of Plasmodium vivax malaria an underestimated problem? Malar J. 2017;16(1):495. doi:10.1186/s12936-017-2143-y.
- Centers for Disease Control and Prevention. Health alert network: locally acquired malaria cases identified in the United States. https://emergency.cdc.gov/han/2023/han00494.asp. Published June 26, 2023.
- Bartoloni A, Zammarchi L. Clinical aspects of uncomplicated and severe malaria. Mediterr J Hematol Infect Dis. 2012;4(1):e2012026. doi:10.4084/mjhid.2012.026.
- Mahon CR, Lehman DC. Textbook of Diagnostic Microbiology. Philadelphia, PA: Elsevier Saunders; 2019.
- Gendrot M, Fawaz R, Dormoi J, et al. Genetic diversity and deletion of Plasmodium falciparum histidine-rich protein 2 and 3: a threat to the diagnosis of P. falciparum malaria. Clin Microbiol Infect. 2019;25(5):580–585. doi:10.1016/j.cmi.2018.09.009.
- Agaba BB, Yeka A, Nsobya S, et al. A systematic review of the status of pfhrp2 and pfhrp3 gene deletion, the approaches and methods used for its estimation, and reporting in Plasmodium falciparum populations in Africa: a review of published studies from 2010 to 2019. Malar J. 2019;18(1):355. doi:10.1186/s12936-019-2987-4.
- World Health Organization. WHO recommends a groundbreaking malaria vaccine for children at risk. October 6, 2021. https://www.who.int/news/item/06-10-2021-who-recommends-groundbreaking-malaria-vaccine-for-children-at-risk. Accessed February 1, 2022.
- Centers for Disease Control and Prevention. Treatment of malaria: guidelines for clinicians (United States). June 28, 2023. https://www.cdc.gov/malaria/diagnosis_treatment/clinicians1.html.
- Mohanty S, Mishra SK, Patnaik R, et al. Brain swelling and mannitol therapy in adult cerebral malaria: a randomized trial. Clin Infect Dis. 2011;53(4):349–355. doi:10.1093/cid/cir405.
- Varo R, Crowley VM, Sitoe A, et al. Adjunctive therapy for severe malaria: a review and critical appraisal. Malar J. 2018;17(1):47. doi:10.1186/s12936-018-2195-7.
- International Association of Oil and Gas Producers. A Guide to Malaria Management Programmes in the Oil and Gas Industry. London, UK: IOGP; 2006.
- Mace KE, Lucchi NW, Tan KR. Malaria surveillance—United States, 2018. MMWR Surveill Summ. 2022;71(SS-8):1–29. doi:10.15585/mmwr.ss7108a1.
- Alonso PL, O’Brien KL. A malaria vaccine for Africa—an important step in a century-long quest. N Engl J Med. 2022;386(11):1005–1007. doi:10.1056/NEJMp2116591.
- Kisalu NK, Idris AH, Weidle C, et al. A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite [published correction appears in Nat Med. 2019 Jan;25(1):188–189]. Nat Med. 2018;24(4):408–416. doi:10.1038/nm.4512.
- Gaudinski MR, Berkowitz NM, Idris AH, et al. A monoclonal antibody for malaria prevention. N Engl J Med. 2021;385:803–814. doi:10.1056/NEJMoa2034031.
- Zalevsky J, Chamberlain AK, Horton HM, et al. Enhanced antibody half-life improves in vivo activity. Nat Biotechnol. 2010;28:157–159. doi:10.1038/nbt.1601.
- Wu RL, Idris AH, Berkowitz NM, et al. Low-dose subcutaneous or intravenous monoclonal antibody to prevent malaria. N Engl J Med. 2022;387(5):397–407. doi:10.1056/NEJMoa2203067.
Epidemiological shifts: the emergence of malaria in America
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.